U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356986) titled 'Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness' on Jan. 12.
Brief Summary: The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their most recent pregnancy.
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Gestational Diabetes
Postpartum
Intervention:
DEVICE: Dexcom Stelo real-time Continuous Glucose Monitor
The Stelo Glucose Biosens...